UNSPSC 85882605: Nonimaging nuclear medicine uptake of thyroid gland using iodine 131 (i-131)

This classification denotes the group of activities that yields an intervention or procedure of nonimaging nuclear medicine uptake of thyroid gland using iodine 131 (i-131). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code CG42GZZ

UNSPSC 85882605 Nonimaging nuclear medicine uptake of thyroid gland using iodine 131 (I-131), a Commodity code, shows no relevant recent state and local procurement activity. The three most recent opportunities posted under this code are unrelated to nuclear medicine services: a diagnostic imaging PACS system procurement from San Mateo Medical Center, a special education contracted services solicitation from Birdville Independent School District in Texas, and a temporary health professional staffing pool from Santa Clara Health System encompassing audiology, cardiology, diagnostic imaging, and therapy services. None of these solicitations involve radiopharmaceutical administration, thyroid uptake testing, or nuclear medicine procedures as implied by the code's scope.

This mismatch suggests either miscategorization at the source or inactive procurement under the code in the state and local market during the recent period. State and local health systems appear to be actively sourcing diagnostic imaging, staffing, and clinical services through competitive solicitations, but not thyroid nuclear medicine uptake services via UNSPSC 85882605 based on the available opportunities. Pursuit under this code warrants verification that actual demand exists within target jurisdictions before investing in capability positioning.